The round was led by NewSpring, via NewSpring Healthcare, the Firm's dedicated, thesis-driven strategy focused on investing in companies that positively impact health outcomes across the care continuum. Existing blue chip healthcare investors, including Peloton Equity, Merck Global Health Innovation Fund, Hamilton Lane, Flexstone Capital, Wave Equity Partners, and Escalate Capital, also participated in the round. This growth capital will be used to support continued customer growth with innovative product development and increased operational capacities.

AeroSafe Global is the leader in biopharmaceutical cold chain solutions, providing 'Cold Chain as a Service' (CCaaS) to ensure the safe, sustainable delivery and effective use of pharmaceuticals. Its comprehensive service offering includes high-tech reusable thermal packaging, outsourced supply chain services, and a temperature monitoring control tower, all part of a pay-per-turn hassle-free program. AeroSafe Global delivers outstanding reliability with significant sustainability benefits through its industry-leading reuse program that reduces carbon usage and landfill by 65% and 90%, respectively, compared to traditional Styrofoam containers.